§ 16-42-23-8 — Federal funding of health care facilities

If:
(1) the federal government indicates that the federal government
will withdraw all federal funds from a health care facility for
allowing amygdalin (laetrile) to be used within the facility; and
(2) providing or allowing use of amygdalin (laetrile) within the
facility would jeopardize the receipt of:
(A) federal funds for reimbursement for Medicare or Medicaid
for all persons within the facility; or
(B) construction funds provided by the federal government
under the Hill-Burton Hospital Construction Program (42
U.S.C. 291 et seq.) or under Title XVI of the Public Health
Services Act (42 U.S.C. 300q-300t);
the hospital or other health care facility may prohibit the use of
amygdalin (laetrile) within the hospital or facility.
[Pre-1993 Recodification Citation: 16-8-8-7(b).]

Legislative History

As added by P.L.2-1993, SEC.25.